First Trust Advisors LP Boosts Holdings in Teladoc Health, Inc. $TDOC

First Trust Advisors LP increased its position in Teladoc Health, Inc. (NYSE:TDOC) by 63.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 350,017 shares of the health services provider’s stock after purchasing an additional 135,520 shares during the period. First Trust Advisors LP owned approximately 0.19% of Teladoc Health worth $1,908,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its holdings in Teladoc Health by 8.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 7,494,255 shares of the health services provider’s stock worth $52,459,000 after buying an additional 605,061 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Teladoc Health by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 4,188,313 shares of the health services provider’s stock valued at $29,324,000 after acquiring an additional 18,394 shares in the last quarter. Jupiter Asset Management Ltd. increased its position in shares of Teladoc Health by 293.9% during the fourth quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock valued at $27,021,000 after acquiring an additional 2,880,008 shares in the last quarter. Nuveen LLC raised its holdings in Teladoc Health by 38.7% in the 4th quarter. Nuveen LLC now owns 2,659,662 shares of the health services provider’s stock worth $18,618,000 after acquiring an additional 742,240 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in Teladoc Health by 11.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,284,697 shares of the health services provider’s stock worth $17,661,000 after acquiring an additional 227,385 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

TDOC has been the topic of several recent analyst reports. Citigroup cut their target price on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research note on Monday, August 3rd. Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Bank of America upped their price target on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Finally, Canaccord Genuity Group dropped their price objective on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. Five investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and a consensus price target of $7.54.

Insider Transactions at Teladoc Health

In other news, insider Fernando M. Rodrigues sold 5,677 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the transaction, the insider directly owned 9,572 shares of the company’s stock, valued at $73,034.36. This represents a 37.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $47,275.48. Following the completion of the transaction, the insider owned 57,671 shares in the company, valued at approximately $440,029.73. This trade represents a 9.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 39,195 shares of company stock valued at $299,058 over the last 90 days. 0.70% of the stock is owned by corporate insiders.

Teladoc Health Stock Up 6.5%

TDOC opened at $7.12 on Friday. The firm has a 50 day moving average price of $8.20 and a 200-day moving average price of $6.55. Teladoc Health, Inc. has a twelve month low of $4.40 and a twelve month high of $9.89. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of -7.19 and a beta of 2.12.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The company had revenue of $606.93 million for the quarter, compared to analysts’ expectations of $615.44 million. During the same quarter last year, the company posted ($0.19) earnings per share. The firm’s quarterly revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, analysts expect that Teladoc Health, Inc. will post -0.88 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.